Evaluation of Intra‐Articular Mesenchymal Stem Cells to Augment Healing of Microfractured Chondral Defects
Authors:
- 22 August 2011
- journal article
- research article
- Published by Wiley in Arthroscopy
- Vol. 27 (11) , 1552-1561
Abstract
Purpose: This study evaluated intra‐articular injection of bone marrow–derived mesenchymal stem cells (BMSCs) to augment healing with microfracture compared with microfracture alone. Methods: Ten horses (aged 2.5 to 5 years) had 1‐cm 2 defects arthroscopically created on both medial femoral condyles of the stifle joint (analogous to the human knee). Defects were debrided to subchondral bone followed by microfracture. One month later, 1 randomly selected medial femorotibial joint in each horse received an intra‐articular injection of either 20 × 10 6 BMSCs with 22 mg of hyaluronan or 22 mg of hyaluronan alone. Horses were confined for 4 months, with hand walking commencing at 2 weeks and then increasing in duration and intensity. At 4 months, horses were subjected to strenuous treadmill exercise simulating race training until completion of the study at 12 months. Horses underwent musculoskeletal and radiographic examinations bimonthly and second‐look arthroscopy at 6 months. Horses were euthanized 12 months after the defects were made, and the affected joints underwent magnetic resonance imaging and gross, histologic, histomorphometric, immunohistochemical, and biochemical examinations. Results: Although there was no evidence of any clinically significant improvement in the joints injected with BMSCs, arthroscopic and gross evaluation confirmed a significant increase in repair tissue firmness and a trend for better overall repair tissue quality (cumulative score of all arthroscopic and gross grading criteria) in BMSC‐treated joints. Immunohistochemical analysis showed significantly greater levels of aggrecan in repair tissue treated with BMSC injection. There were no other significant treatment effects. Conclusions: Although there was no significant difference clinically or histologically in the 2 groups, this study confirms that intra‐articular BMSCs enhance cartilage repair quality with increased aggrecan content and tissue firmness. Clinical Relevance: Clinical use of BMSCs in conjunction with microfracture of cartilage defects may be potentially beneficial.Keywords
Funding Information
- Steadman Philippon Research Institute
- Colorado State University
- Steadman Philippon Research Institute
This publication has 26 references indexed in Scilit:
- Management of Articular Cartilage Defects of the KneeJournal of Bone and Joint Surgery, 2010
- MicrofractureCARTILAGE, 2010
- Outcomes of Full‐Thickness Articular Cartilage Injuries of the Shoulder Treated With MicrofractureArthroscopy, 2009
- IL-1ra/IGF-1 Gene Therapy Modulates Repair of Microfractured Chondral DefectsClinical Orthopaedics and Related Research, 2007
- Effects of Calcified Cartilage on Healing of Chondral Defects Treated with Microfracture in HorsesThe American Journal of Sports Medicine, 2006
- Mobilization of bone marrow‐derived mesenchymal stem cells into the injured tissues after intraarticular injection and their contribution to tissue regenerationKnee Surgery, Sports Traumatology, Arthroscopy, 2006
- Microfracture Chondroplasty:Sports Medicine and Arthroscopy Review, 2003
- Outcomes of microfracture for traumatic chondral defects of the knee: Average 11‐year follow‐upArthroscopy, 2003
- Early Events in Cartilage Repair After Subchondral Bone MicrofractureClinical Orthopaedics and Related Research, 2003
- Arthroscopic Subchondral Bone Plate Microfracture Technique Augments Healing of Large Chondral Defects in the Radial Carpal Bone and Medial Femoral Condyle of HorsesVeterinary Surgery, 1999